Evidence map›Paper›PMID 26096188›Full record

ArticleJournal of ethnopharmacology2015

Immuno-stimulatory activity of a polysaccharide-enriched fraction of Sutherlandia frutescens occurs by the toll-like receptor-4 signaling pathway.

Wei Lei, Jimmy D Browning, Peggy A Eichen, Chi-Hua Lu, Valeri V Mossine, George E Rottinghaus, William R Folk, Grace Y Sun, Dennis B Lubahn, Kevin L Fritsche

Abstract read
In one paragraph

Article in Journal of ethnopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Activation of RAW264.7 cells by PCp-I, a polysaccharide fromInternational journal of immunopathology and pharmacology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Wei LeiDivision of Animal Sciences, University of Missouri, Columbia, MO 65211, USA.
Jimmy D BrowningDivision of Animal Sciences, University of Missouri, Columbia, MO 65211, USA.
Peggy A EichenDivision of Animal Sciences, University of Missouri, Columbia, MO 65211, USA.
Chi-Hua LuDivision of Animal Sciences, University of Missouri, Columbia, MO 65211, USA.
Valeri V MossineDepartment of Biochemistry, University of Missouri, Columbia, MO 65211, USA.
George E RottinghausVeterinary Medical Diagnostic Laboratory, University of Missouri, Columbia, MO 65211, USA.
William R FolkDepartment of Biochemistry, University of Missouri, Columbia, MO 65211, USA.
Grace Y SunDepartment of Biochemistry, University of Missouri, Columbia, MO 65211, USA.
Dennis B LubahnDepartment of Biochemistry, University of Missouri, Columbia, MO 65211, USA.
Kevin L FritscheDivision of Animal Sciences, University of Missouri, Columbia, MO 65211, USA; Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO 65211, USA. Electronic address: FritscheK@missouri.edu.
University of Missouri · US

Funding

The Interactions Core/Mark McintoshP50AT006273 · NCCIH · UNIVERSITY OF MISSOURI-COLUMBIA · PI LUBAHN, DENNIS B · 2010 to 2014
$7.4M
Treatment of cystic fibrosis with soy derived isoflavonesP01ES010535 · NIEHS · UNIVERSITY OF MISSOURI-COLUMBIA · PI LUBAHN, DENNIS B · 2000 to 2005
$5.9M
NCCIH NIH HHS P50 AT006273NCCIH NIH HHS P50AT006273NIEHS NIH HHS P01 ES010535
6 · The paper itself

Abstract

ethnopharmacological relevanceSutherlandia frutescens (L.) R. Br. is an indigenous plant of southern Africa that has been traditionally used for various cancers, infections, and inflammatory conditions. AIM OF THE STUDY: Our aim was to investigate the potential immuno-stimulatory activity of a polysaccharide-enriched fraction (SFPS) from a decoction of S. frutescens. MATERIALS AND

methodsRAW 264.7 cells (a murine macrophage cell line) were used to determine the activities of SFPS on macrophage function. The production of reactive oxygen species (ROS), nitric oxide (NO), and inflammatory cytokines were evaluated in the cells treated with or without SFPS. CLI-095, a toll-like receptor (TLR) 4-specific inhibitor, was used to identify whether or not SFPS exerts its effects through TLR4. An antagonist of endotoxin, polymyxin B, was used to evaluate whether endotoxin present in SFPS contributed to its immune-stimulatory activity.

resultsSFPS exhibited potent immune-stimulatory activity by macrophages. The production of ROS, NO, and tumor necrosis factor (TNF-α) were increased upon exposure to SFPS in a dose-dependent manner. All of these activities were completely blocked by co-treatment with CLI-095, but only partially diminished by polymyxin B.

conclusionWe demonstrate for the first time potent immune-stimulatory activity in a decoction prepared from S. frutescens. We believe that this immune stimulatory activity is due, in part, to the action of polysaccharides present in the decoction that acts by way of TLR4 receptors and the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway. These findings provide a plausible mechanism through which we can understand some of the medicinal properties of S. frutescens.

Indexed as

AnimalsCell LineCytokinesFabaceaeMacrophagesMedicine, African TraditionalMiceNF-kappa BNitric OxidePlant ExtractsPolysaccharidesReactive Oxygen SpeciesSignal TransductionToll-Like Receptor 4CytokinesNF-kappa BNitric OxidePlant ExtractsPolysaccharidesReactive Oxygen SpeciesTlr4 protein, mouseToll-Like Receptor 4EndotoxinMacrophagePolysaccharidesSutherlandia frutescensToll-like receptor 4

Identifiers

PMID26096188
PMCPMC4523454
OpenAlexW624645021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.